9th Annual Global Transparency Reporting Congress
February 20 - 21, 2019 - Amsterdam MA USCBI a division of UBM Americas
roberts.apse@cbinet.com
Phone:+1-339-298-2290
Uniting Payers, Providers and Manufacturers to Increase Market Access and Identify Value Ecosystems for Mature and Emerging Oncologic Therapies As the marketplace makes room for new and diverse treatment options it is more important than ever to have a clear “go-to-market strategy.” CBI’s 12th Annual Oncology Market Access Strategy Summit will bring together the various stakeholders involved in commercializing new oncologic therapies to ensure manufacturers have the tools needed to identify value networks early in the product lifecycle and ensure proper reimbursement channels are in place.
This website uses cookies to ensure you get the best experience on our website. Learn more